NewsRoom Articles - Page 80 of 214

MondayMar 06, 2023 1:26 pm

Climate Change Heightening Risk of Global Infectious Illnesses

The COVID-19 pandemic showed us just how quickly an infectious disease can spread in our modern interconnected world. Just a few months after the disease was first discovered in Wuhan, China, it had spread to most continents and shut down dozens of economies across the world. Even though we are now past the worst of the pandemic, it seems that infectious diseases will keep humanity on its toes for much longer than we thought. A recent analysis has revealed that climate change has significantly increased the world’s risk of infectious diseases. The analysis states that climate change has already upped…

FridayMar 03, 2023 10:59 am

Study Finds Exposure to Traffic Noise Increases Risk of Tinnitus

While living in urban areas brings plenty of benefits to its residents, it is not always beneficial to their health. For starters, urban dwellers are exposed to a lot more air pollution compared to people living in rural areas. They are also more likely to be infected with communicable diseases due to the dense populations of most cities. And now a recent study has revealed that increased noise levels in urban areas can do more than just annoy residents. The study found that people are more likely to develop tinnitus if they are exposed to traffic noise in their homes.…

FridayMar 03, 2023 10:30 am

India Globalization Capital Inc. (NYSE American: IGC) Leads the Way Forward with Revolutionary Cannabis-Based Treatment for Alzheimer’s Symptoms

Company’s investigational drug is being tested for the first time ever on humans in an FDA-approved study In phase 1 studies, IGC-AD1 shows potential to safely reduce debilitating symptoms IGC is actively building a portfolio of both cannabis-based and manufactured molecules that can address multiple areas of unmet medical needs In groundbreaking work that establishes its commitment to being a pioneer in the treatment of Alzheimer’s disease, India Globalization Capital (NYSE American: IGC) is developing a cannabis-based investigational drug that is being tested for the first time ever on humans in an FDA-approved study (https://ibn.fm/qsc42). The company is developing its…

FridayMar 03, 2023 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact

During interview, Vajdic recounts first steps of journey in the United States CEO points to key lessons he learned that helped him found HeartBeam The company has developed the first and only 3D-vector 12-lead electrocardiogram (“ECG”) platform for heart attack detection anytime, anywhere Growing up in Yugoslavia (now Serbia) as the only child of a well-known surgeon, HeartBeam (NASDAQ: BEAT) CEO and founder Branislav Vajdic, PhD, felt some pressure to study medicine and follow in his father’s footsteps. One day, at his father’s insistence, Vajdic observed a surgery — and fainted the moment he saw the first drop of blood.…

ThursdayMar 02, 2023 12:00 pm

Study Finds Organ Transplant Recipients Undervaccinated

A recent study has revealed that organ transplant patients of lower socioeconomic status are likely to be unvaccinated against pneumococcus and influenza. The study also found that area of residence affected whether or not solid organ transplant patients were suitably vaccinated against these two diseases. It is extremely crucial that patients who are set to receive solid organs be adequately vaccinated against Streptococcus pneumonia and influenza because these patients are immunosuppressed. Since they are on immunosuppressants, solid organ transplant patients may find it hard to fight off even simple infections such as the common cold. These patients are more likely…

ThursdayMar 02, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Nano-sized Molecules Show Powerful Impact in Preclinical Studies

BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company’s alpaca-derived nanosized antibodies (“NanoAbs”) exhibit superior valuable competitive advantages over commercially available monoclonal antibodies (“mAbs”), including better specificity and affinity to the target, hyper-thermostability, and potential for more effective and convenient routes of administration Preclinical in vivo data have shown its lead drug candidate, the inhaled anti-SARS-CoV-2 NanoAb, led to a significantly shorter and milder illness, virtually eliminated the virus from the lungs, and effectively prevented illness when administered prophylactically BiondVax aims to fill the void in COVID-19 therapeutics and is forging ahead…

WednesdayMar 01, 2023 11:09 am

Study Finds Chronic Pain Increases Risk of Developing Dementia

Chronic pain is a long-standing pain that occurs together with another chronic illness such as arthritis or cancer. Chronic pain has been linked to depression, anxiety, restrictions in mobility and daily activities, increased health care costs, poor quality of life and dependence on opioids. Now, new research has found that an individual’s risk of cognitive decline and dementia heightens if they suffer from chronic pain that lasts for more than three months. The study was carried out by researchers at the Chinese Academy of Sciences in Beijing. Professor Tu Yiheng, who was the study’s corresponding author, is a psychology professor…

TuesdayFeb 28, 2023 12:50 pm

Researchers Find Balancing Ability May Predict Risk of Cognitive Decline

Investigators at the University of Tsukuba have discovered that physical balance can be used to predict an individual's risk of mild cognitive impairment and Alzheimer’s disease (AD). The researchers found that physicians may be able to identify patients who have higher chances of developing the neurological disease by measuring their physical balance. Alzheimer’s disease is usually precipitated by mild cognitive impairment, a condition that results in a minor decline in cognitive function. This stage of cognitive decline is characterized by problems with memory, judgment or language and is usually followed by severe cognitive decline if left untreated. Given that the…

MondayFeb 27, 2023 12:24 pm

Risk Factors of Age-Related Macular Degeneration

Age-related macular generation is an ocular disease that causes a reduction in central vision as individuals grow older. The condition is caused when a region of the retina called the macular becomes damaged and causes patients to lose the ability to see fine details; it can also be referred to as central vision. While age-related macular degeneration (ARMD) rarely causes blindness, it is the number one cause of severe eyesight loss in people aged 50 and above. Individuals suffering from the advanced stages of this ailment often lose the ability to see faces, drive and read the small print. By…

FridayFeb 24, 2023 11:05 am

Study Finds Eczema Cases Increasing Among Children

Eczema is a condition that causes an individual’s skin to become dry, itchy and cracked; in some cases, skin can even ooze. Some types of eczema, such as dyshidrotic eczema, can cause blisters. Data from the National Eczema Association indicates more than 31 million individuals in the U.S. suffer from eczema. While it can flare up at any age, this chronic skin condition is common in young children. It is estimated that about 9.6 million children below 18 years of age suffer from atopic dermatitis. Experts believe that this skin condition is more prevalent in higher-income areas, which are more…